Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

M Ponz-Sarvisé, PA Nguewa, MJ Pajares… - Clinical Cancer …, 2011 - AACR
Purpose: High inhibitor of differentiation-1 (Id1) levels have been found in some tumor types.
We aimed to study Id1 levels and their prognostic impact in a large series of stages I to IV …

[HTML][HTML] MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo

Y Zeng, J Zhu, D Shen, H Qin, Z Lei, W Li, Z Liu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Despite advances in diagnosis and treatment, the survival of non-small cell lung cancer
(NSCLC) patients remains poor; therefore, improved understanding of the disease …

Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells

Z Hu, Q Zeng, B Zhang, H Liu, W Wang - Biochimie, 2014 - Elsevier
Abstract p53 signaling plays an important role in cell death. Zerumbone, a natural cyclic
sesquiterpene, has shown cytotoxic activity against many cancers. This study was done to …

Survivorship issues for patients with lung cancer

CLP Pozo, MAA Morgan, JE Gray - Cancer Control, 2014 - journals.sagepub.com
Background: Survivorship concerns for patients with lung and bronchus cancers include
quality of life and physical and psychological aspects. Recommendations for follow-up care …

[HTML][HTML] Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 …

XM Xu, Y Zhang, D Qu, XW Feng… - Molecular …, 2012 - spandidos-publications.com
Osthole, a natural compound, may be extracted from Cnidium monnieri and other medicinal
plants. Previous studies have shown that osthole has anticancer effects in various human …

[HTML][HTML] Prognostic value of microRNAs in lung cancer: A systematic review and meta‑analysis

W Xiao, Y Zhong, L Wu, D Yang… - Molecular and …, 2019 - spandidos-publications.com
Lung cancer is one of the leading causes of cancer‑associated mortality throughout the
world. The prognosis of the disease depends on many factors including the stage and type …

Metastasis of primary lung carcinoma to the breast: a systematic review of the literature

JA Mirrielees, JH Kapur, LM Szalkucki… - Journal of Surgical …, 2014 - Elsevier
Background The purpose of this systematic review was to summarize previously published
case reports of primary lung carcinoma metastasis to the breast to assess common clinical …

[HTML][HTML] Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine

S Ozkaya, S Findik, A Dirican… - Experimental and …, 2012 - spandidos-publications.com
Limited data exist concerning the long-term (≥ 5 year) survival rates of patients with stage
IIIB and IV non-small cell lung carcinoma (NSCLC) receiving chemotherapy. We aimed to …

[HTML][HTML] Impact of genetic polymorphisms on the metabolic pathway of vitamin d and survival in non-small cell lung cancer

LE Pineda Lancheros, C Pérez Ramírez… - Nutrients, 2021 - mdpi.com
Vitamin D has been associated with risk, development, and progression of cancer. However,
the genes involved in its metabolism are highly polymorphic, compromising its activity. The …

PET Imaging of Tumor Neovascularization in a Transgenic Mouse Model with a Novel 64Cu-DOTA-Knottin Peptide

CH Nielsen, RH Kimura, N Withofs, PT Tran, Z Miao… - Cancer research, 2010 - AACR
Due to the high mortality of lung cancer, there is a critical need to develop diagnostic
procedures enabling early detection of the disease while at a curable stage. Targeted …